Herrlinger KR - Search Results

1

Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.

Gersemann M, Becker S, Kübler I, Koslowski M, Wang G, Herrlinger KR, Griger J, Fritz P, Fellermann K, Schwab M, Wehkamp J, Stange EF. Gersemann M, et al. Among authors: herrlinger kr. Differentiation. 2009 Jan;77(1):84-94. doi: 10.1016/j.diff.2008.09.008. Epub 2008 Oct 22. Differentiation. 2009. PMID: 19281767

2

[Azathioprine in chronic inflammatory bowel diseases. Evidence base].

Herrlinger K, Stange EF. Herrlinger K, et al. Med Klin (Munich). 2000 Apr 15;95(4):201-6. doi: 10.1007/pl00002107. Med Klin (Munich). 2000. PMID: 10808301 Review. German.

3

The pancreas and inflammatory bowel diseases.

Herrlinger KR, Stange EF. Herrlinger KR, et al. Int J Pancreatol. 2000 Jun;27(3):171-9. doi: 10.1385/IJGC:27:3:171. Int J Pancreatol. 2000. PMID: 10952399 Review.

4

Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.

Herrlinger KR, Noftz MK, Fellermann K, Schmidt K, Steinhoff J, Stange EF. Herrlinger KR, et al. Aliment Pharmacol Ther. 2001 Mar;15(3):363-9. doi: 10.1046/j.1365-2036.2001.00940.x. Aliment Pharmacol Ther. 2001. PMID: 11207511 Free article.

5

[Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus].

Fellermann K, Rudolph B, Witthöft T, Herrlinger KR, Tronnier M, Ludwig D, Stange EF. Fellermann K, et al. Among authors: herrlinger kr. Med Klin (Munich). 2001 Feb 15;96(2):105-8. doi: 10.1007/pl00002176. Med Klin (Munich). 2001. PMID: 11253280 German.

6

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.

Fellermann K, Herrlinger KR, Witthoeft T, Homann N, Ludwig D, Stange EF. Fellermann K, et al. Among authors: herrlinger kr. Transplant Proc. 2001 May;33(3):2247-8. doi: 10.1016/s0041-1345(01)01979-0. Transplant Proc. 2001. PMID: 11377517 Clinical Trial. No abstract available.

7

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.

Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Herrlinger KR, et al. Am J Gastroenterol. 2002 Feb;97(2):377-81. doi: 10.1111/j.1572-0241.2002.05473.x. Am J Gastroenterol. 2002. PMID: 11866276

8

Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.

Wehkamp J, Schwind B, Herrlinger KR, Baxmann S, Schmidt K, Duchrow M, Wohlschläger C, Feller AC, Stange EF, Fellermann K. Wehkamp J, et al. Among authors: herrlinger kr. Dig Dis Sci. 2002 Jun;47(6):1349-55. doi: 10.1023/a:1015334917273. Dig Dis Sci. 2002. PMID: 12064812

9

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF. Wehkamp J, et al. Among authors: herrlinger kr. Eur J Gastroenterol Hepatol. 2002 Jul;14(7):745-52. doi: 10.1097/00042737-200207000-00006. Eur J Gastroenterol Hepatol. 2002. PMID: 12169983

10

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

Fellermann K, Tanko Z, Herrlinger KR, Witthoeft T, Homann N, Bruening A, Ludwig D, Stange EF. Fellermann K, et al. Among authors: herrlinger kr. Inflamm Bowel Dis. 2002 Sep;8(5):317-24. doi: 10.1097/00054725-200209000-00002. Inflamm Bowel Dis. 2002. PMID: 12479646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters